Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
. An existing team with expertise and drive to move forward synthetic biology in cancer immunotherapy. A well-structured on-boarding process and clear responsibilities. A highly professional and supportive
-
to gain further qualifications. We offer our employees a broad spectrum of career opportunities in an attractive working professional environment (https://www.dwi.rwthaachen.de/seite/institutskultur). DWI
-
scaffolds using electrospinning. Characterizing their physical, chemical, and mechanical properties. Modifying the scaffolds through process parameters, chemical synthesis and crosslinking strategies
-
). The WZB Berlin Social Science Center is a publicly financed research institution that conducts leading edge theory-based and problem-oriented social science research (http://www.wzb.eu/en ). WZB researchers
-
be submitted via our career portal (https://gwzo.jobs.personio.de/ ) or by email (bewerbung(at)leibniz-gwzo.de ). Please note that submitting an application by email may have data protection
-
and German legal regulations. Further information on data protection and the processing of personal data can be found at: https://www.isas.de/en/datenschutz . The closing date for applications is
-
obligation at the University of Potsdam (usually 2 hours per week per semester) in accordance with the Brandenburg Higher Education Act (BbgHG). The hiring process is subject to the requirements set forth in
-
candidate will have access to state-of-the-art next-generation sequencing platforms, bioinformatics resources, and biosafety level 2 laboratory facilities, offering excellent conditions for doctoral training
-
networks are rewired in response to physiological or pathophysiological stimuli. The project will be conducted jointly with the 'Structural Interactomics Group' led by Prof. Fan Liu (https
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu/ ) - is a biomedical research center focusing on translational immunology in the fields of cancer